Related Experiment Video
Updated: Jan 23, 2026

Generation of Recombinant Arenavirus for Vaccine Development in FDA-Approved Vero Cells
Published on: August 1, 2013
Remogliflozin Etabonate: First Global Approval.
1Springer Nature, Private Bag 65901, Mairangi Bay, Auckland, 0754, New Zealand. dru@adis.com.
Remogliflozin etabonate, a novel sodium-glucose co-transporter subtype 2 inhibitor, has gained its first approval for treating type 2 diabetes mellitus in India. This marks a significant milestone in the development of this new diabetes medication.
Area of Science:
- Pharmacology
- Endocrinology
- Drug Development
Background:
- Type 2 diabetes mellitus (T2DM) remains a global health challenge requiring novel therapeutic agents.
- Sodium-glucose co-transporter subtype 2 (SGLT2) inhibitors represent a promising class of antidiabetic drugs.
- Remogliflozin etabonate is a prodrug designed for effective delivery of remogliflozin.
Purpose of the Study:
- To summarize the key developmental milestones of remogliflozin etabonate.
- To highlight the journey leading to its recent first approval for T2DM treatment in India.
Main Methods:
- Review of preclinical and clinical development data.
- Analysis of regulatory submission and approval processes.
- Identification of critical steps in drug formulation and efficacy studies.
Main Results:
- Remogliflozin etabonate has successfully completed development phases.
- The drug has received its first marketing authorization for T2DM in India.
- Development milestones included formulation as a prodrug and demonstration of efficacy.
Conclusions:
- Remogliflozin etabonate's approval signifies a new treatment option for T2DM patients in India.
- The development pathway demonstrates successful progression from research to market authorization.
- Further research may explore broader applications and global market expansion.
Related Concept Videos
FDA Approved Drugs: Changes to Approved Drugs
Global Climate Change
Introduction to Global Positioning System
Global Regulatory Systems
Errors in Global Positioning System
Field Application of Global Positioning System

